Published in
American Society for Clinical Investigation, Journal of Clinical Investigation, 4(129), p. 1641-1653, 2019
DOI: 10.1172/jci123049
Links
Tools
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth
Journal article published in 2019 by
Shaikamjad Umesalma,
Courtney A. Kaemmer,
Jordan L. Kohlmeyer,
Blake Letney,
Angela M. Schab 
,
Jacqueline A. Reilly,
Ryan M. Sheehy,
Jussara Hagen,
Nitija Tiwari,
Fenghuang Zhan,
Mariah R. Leidinger,
Thomas M. O’Dorisio,
Joseph Dillon,
Ronald A. Merrill ,
David K. Meyerholz
and other authors.
,
Jacqueline A. Reilly,
Ryan M. Sheehy,
Jussara Hagen,
Nitija Tiwari,
Fenghuang Zhan,
Mariah R. Leidinger,
Thomas M. O’Dorisio,
Joseph Dillon,
Ronald A. Merrill ,
David K. Meyerholz
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 